Alcon Buys Aerie, Reaffirming Commitment To Pharma Space

eye drops
Alcon is investing in eye drugs with Aerie acquisition • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business